GeoVax jumps on patent for cancer vaccine in China

Geovax Labs

24/05/2022 15:28

** GeoVax Labs' shares  GOVX.O  up 13% at $2.62 in early
trade
    ** Gets patent for cancer vaccine in China  urn:newsml:reuters.com:*:nGNX1n3zp5
    ** Co adds patent covers co's vaccine platform called
GV-MVA-VLP, which can be used to cover a wide range of cancers,
including breast, colon, ovarian, prostate, pancreatic and lung 
    ** Stock down nearly 28% this year despite session's gains
and after nearly quadrupling since Thursday over monkeypox cases
in the United States and Europe  urn:newsml:reuters.com:*:nL3N2XF2RW

 (Reporting by Leroy Leo in Bengaluru)
 ((Leroy.Dsouza@thomsonreuters.com ; Twitter: https://twitter.com/LeroyLeo7;))